Acute Myelocytic Leukemia

Search Trials
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
Status:
Completed
Last Changed:
Jun 27, 2018
First Changed:
Apr 2, 2014
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Cytosine Arabinoside
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Aug 24, 2018
First Changed:
Jul 30, 2014
Disease(s):
Acute Myeloid Leukemia, in Relapse
Intervention(s):
GO-203-2cGO-203-2c + Decitabine
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
Status:
Terminated
Last Changed:
Nov 22, 2018
First Changed:
Nov 20, 2015
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AGS67E
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Aug 15, 2018
First Changed:
Nov 29, 2016
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Standard Leukemia CarePalliative Care
Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients
Status:
Unknown status
Last Changed:
Apr 21, 2015
First Changed:
Jun 28, 2013
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Idarubicin

Connect. Empower. Inspire.